-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FCCFZ9WEq6eOQx9wXgAbjpFkaVsJXhkNpp8ysKWIrLDr/kKuk1ZIJlnk+VCa/11y JExfVTToqAKmqRG4udPVlQ== 0001036050-98-000219.txt : 19980218 0001036050-98-000219.hdr.sgml : 19980218 ACCESSION NUMBER: 0001036050-98-000219 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980217 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MEDICAL TECHNOLOGY & INNOVATIONS INC /FL/ CENTRAL INDEX KEY: 0000847464 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-AMUSEMENT & RECREATION SERVICES [7900] IRS NUMBER: 652954561 STATE OF INCORPORATION: FL FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-50779 FILM NUMBER: 98543248 BUSINESS ADDRESS: STREET 1: 3125 NOLT RD CITY: LANCASTER STATE: PA ZIP: 17631 BUSINESS PHONE: 7178926770 MAIL ADDRESS: STREET 1: 3125 NOLT RD CITY: LANCASTER STATE: PA ZIP: 17601 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: EMERALD ADVISERS INC /PA/ /ADV CENTRAL INDEX KEY: 0000881235 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 232664857 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 1857 WILLIAM PENN WAY STREET 2: STE 204 CITY: LANCASTER STATE: PA ZIP: 17601 BUSINESS PHONE: 7173961116 MAIL ADDRESS: STREET 1: P O BOX 10666 CITY: LANCASTER STATE: PA ZIP: 17605 FORMER COMPANY: FORMER CONFORMED NAME: EMERALD ADVISERS INC /PA/ /ADV DATE OF NAME CHANGE: 19970207 SC 13G 1 SCHEDULE 13G -------------------------- OMB APPROVAL -------------------------- OMB Number: 3235-0145 Expires: December 31, 1997 Estimated average burden hours per response. . .14.90 -------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ______)* Medical Technology & Innovations, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Medical Technology & Innovations, Inc. Common Stock par value none. - -------------------------------------------------------------------------------- (Title of Class of Securities) 58462M100 ---------------------------------- (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 4 pages SEC 1745 (2095) - ----------------------- --------------------- CUSIP NO. 58462M100 13G PAGE 2 OF 4 PAGES - ----------------------- --------------------- - ------------------------------------------------------------------------------ NAME OF REPORTING PERSON 1 I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Emerald Advisers, Inc. - ------------------------------------------------------------------------------ CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* 2 (a) [_] (b) [_] - ------------------------------------------------------------------------------ SEC USE ONLY 3 - ------------------------------------------------------------------------------ CITIZENSHIP OR PLACE OF ORGANIZATION 4 Pennsylvania - ------------------------------------------------------------------------------ SOLE VOTING POWER 5 NUMBER OF 1,510,789 SHARES ----------------------------------------------------------- SHARED VOTING POWER BENEFICIALLY 6 0 OWNED BY ----------------------------------------------------------- EACH SOLE DISPOSITIVE POWER 7 REPORTING 1,804,789 PERSON ----------------------------------------------------------- SHARED DISPOSITIVE POWER WITH 8 0 - ------------------------------------------------------------------------------ AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9 1,804,789 - ------------------------------------------------------------------------------ CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* 10 [_] - ------------------------------------------------------------------------------ PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 11 10.5% - ------------------------------------------------------------------------------ TYPE OF REPORTING PERSON* 12 IA - ------------------------------------------------------------------------------ *SEE INSTRUCTIONS BEFORE FILLING OUT! Schedule 13G Page 3 of 4 Emerald Advisers, Inc. Item 1. (a) The name of the issuer is Medical Technology & Innovations, Inc. (b) The address of issuer's principal executive offices is 3125 Nolt Road, Lancaster, PA 17601. Item 2. (a) The name of the person filing is Emerald Advisers, Inc. (b) The address of the principal business office of person filing is 1857 William Penn Way, Lancaster, Pennsylvania 17601. (c) The state of organization is Pennsylvania. (d) The title of the class of security is common stock par value none. (e) The CUSIP number is 58462M100. Item 3. (e) The person filing is an Investment Adviser registered under section 203 of the Investment Advisers Act of 1940. Item 4. (a) The amount beneficially owned is 1,804,789. (b) The percent of class is 10.5%. (c)(i) The number of shares as to which Emerald Advisers, Inc. has sole voting power is 1,510,789. (c)(ii) The number of shares as to which Emerald Advisers, Inc. has shared voting power is 0. (c)(iii) The number of shares as to which Emerald Advisers, Inc. has sole dispositive power is 1,804,789. (c)(iv) The number of shares as to which Emerald Advisers, Inc. holds shared dispositive power is 0. Schedule 13G Page 4 of 4 Emerald Advisers, Inc. Item 5. Not applicable. Item 6. Other persons have the right to receive and/or the power to direct the receipt of dividends from, and the proceeds from the sale of, such securities. Item 7. Not applicable. Item 8. Not applicable. Item 9. Not applicable. Item 10. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. ------------------------------------ Date ------------------------------------ Signature Scott L. Rehr, Senior Vice President -----END PRIVACY-ENHANCED MESSAGE-----